1. Arno A.I., Amini- Nik S., Blit P.H., Al- Shehab M., Belo C., Herer E., Jeschke M.G. (2014). Effect of human Wharton’s jelly mesenchymal stem cell paracrine signaling on keloid fibroblasts. Stem Cells Transl. Med., 3: 299-307.10.5966/sctm.2013-0120
2. Atsuta I., Liu S., Miura Y., Akiyama K., Chen C., An Y., Shi S., Chen F.M. (2013). Mesenchymal stem cells inhibit multiple myeloma cells via the Fas/Fas ligand pathway. Stem Cell Res. Ther., 4: 111.10.1186/scrt322
3. Bogliolo L., Ariu F., Leoni G., Uccheddu S., Bebbere D. (2011). High hydrostatic pressure treatment improves the quality of in vitro-produced ovine blastocysts. Reprod. Fertil. Dev., 23: 809-817.
4. Bourin P., Gadelorge M., Peyrafitte J.A., Fleury-Cappellesso S., Gomez M., Ragea C., Sensebé L. (2008). Mesenchymal progenitor cells: tissue origin, isolation and culture. Transfus. Med. Hemother., 35: 160-167.
5. Cui J.J., Chi Y., Du W.J., Yang S.G., Li X., Chen F., Ma F.X., Lu S.H., Han Z.C. (2013). Human umbilical cord mesenchymal stem cells reduce the sensitivity of HL-60 cells to cytarabine. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 21: 760-764.